1. Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy. Issue 9 (30th October 2018) Authors: Wortman, B.; Creutzberg, C.; Putter, H.; Jürgenliemk-Schulz, I.; Jobsen, J.; Lutgens, L.; Steen-Banasik, E.; Mens, J.; Slot, A.; Kroese, M.; Triest, B.; Nijman, H.; Stelloo, E.; Bosse, T.; Boer, S.; Putten, W.; Smit, V.; Nout, R. Journal: British journal of cancer Issue: Volume 119:Issue 9(2018) Page Start: 1067 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗